Funded Startups in South San Francisco, Pennsylvania

Discover the intent signals your CRM is missing

Onepot.ai offers automated synthesis of small molecules from basic building blocks using a unified, end-to-end process.

InterVene is a medical device company that treats severe venous disease in the legs.

Spirair is a medical device company that offers minimally invasive solutions for nasal septum deviation treatment.

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

Glydways designs and implements personal rapid transit systems using self-driving vehicles.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Addition Therapeutics develops RNA-only therapeutics using PRINT technology for genetic medicine.

Yellow is a financial services provider of software, analytics, and investments in blockchain startups.

Wildwonder produces beverages that offer sparkling infusions which are crafted with antioxidants for good gut health.

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

Earli develops genetic constructs for early cancer detection and targeted therapy.

Deep Origin is a biotechnology company that offers a platform for life sciences R&D.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Convoke is curating high-quality datasets, automating workflows, and building a software platform.

Whirl AI develops an AI-driven platform and agents to understand and modernize complex enterprise IT applications and business processes.

Quill Meetings develops Quilliam, an on-device AI staff coordination and meeting intelligence platform for professionals.

Ebb Carbon works on a reverse electrochemical ocean deacidification process that captures CO2 from the atmosphere.